Immunological and molecular diagnosis of cysticercosis

Pathogens and Global Health

Volumn 106, Issue 5, 2012, Pages 286-298

  Rodriguez, Silvia ^a   Wilkins, Patricia ^b   Dorny, Pierre ^c  

^a INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Antibody; Antigen; Cysticercosis; Immunodiagnosis; Neurocysticercosis; Serology; Taenia solium; Western blot

Indexed keywords

IMMUNOGLOBULIN G;

ANTIBODY DETECTION; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CYSTICERCOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOLOGY; MOLECULAR DIAGNOSIS; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; QUALITY OF LIFE; SEIZURE; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; TAENIA HYDATIGENA; TAENIA SOLIUM;

ANIMALS; CYSTICERCOSIS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PARASITOLOGY; POINT-OF-CARE SYSTEMS; SEROLOGIC TESTS; TAENIA SOLIUM;

EID: 84874847859     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1179/2047773212Y.0000000048     Document Type: Article

References (181)

1. Moses A. Dos metodos biolojicos de diagnostico nas cisticercozes. Mem Inst Oswaldo Cruz. 1911;3:322-326.
2. Waterhouse R. Cysticercus cellulosae in the central nervous system: with an account of two cases. Q J Med. 1913;6:469-485.
3. Weinberg M. Recherche des anticorps specifiques dans la distomatose et la cysticercose. C R Soc Biol Paris. 1909;66:219-221.
4. Takayanagui OM, Jardim E. [Clinical aspects of neurocysti- cercosis: analysis of 500 cases]. Arq Neuro-psiquiatr. 1983;41:50-63.
5. Salinas P, Sandoval L, Rugiero E, Contreras MC. [Diagnosis of human neurocysticercosis by ELISA-IgG using a purified antigen]. Bol Chil Parasitol. 1996;51:85-90.
6. Bueno EC, Snege M, Vaz AJ, Leser PG. Serodiagnosis of human cysticercosis by using antigens from vesicular fluid of Taenia crassiceps cysticerci. Clin Diagn Lab Immunol. 2001;8:1140-1144.
7. Teive HA, de Almeida SM, Werneck LC. The Brazilian contribution to the study of neurocysticercosis: Moses and Lange's role in cerebrospinal fluid diagnosis. Arq Neuro- psiquiatr. 2006;64:534-537.
8. Garcia HH, Gilman RH, Catacora M, Verastegui M, Gonzalez AE, Tsang VC. Serologic evolution of neurocysti- cercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru. J Infect Dis. 1997;175:486-489.
9. Ito A, Craig PS. Immunodiagnostic and molecular approaches for the detection of taeniid cestode infections. Trends Parasitol. 2003;19:377-381.
10. Rodriguez S, Dorny P, Tsang VC, Pretell EJ, Brandt J, Lescano AG, et al. Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extra- parenchymal neurocysticercosis. J Infect Dis. 2009;199:1345-1352.
11. Biagi F, Navarrete F, Pina A, Santiago AM, Tapia L. Study of 3 serological reactions in the diagnosis of cysticercosis. Rev Med Hosp Gen (Mex). 1961;24:501-508.
12. Biagi F, Tay J. A precipitation reaction for the diagnosis of cysticercosis. Am J Trop Med Hyg. 1958;7:63-65.
13. Flisser A, Tarrab R, Willms K, Larralde C. Immunoelectrophoresis and double immunodiffusion in the diagnosis of human cerebral cysticercosis. Arch Invest Med. 1975;6:1-12.
14. Flisser A, Bulnes I, Diaz ML, Luna R, Woodhouse E, Beltran F, et al. Seroepidemiologic study of human cysticerosis in the predominantly indigenous rural Indian population of the State of Chiapas. Arch Invest Med. 1976;7:107-113.
15. Schoop G, Lamina J. Immunological evidence of cysticercosis in the living animal. I. Allergic intracutaneous test. Deutsch Tierarztl Wochenschr. 1970;77:156-161.
16. Schenone H, Aranda R, Concha L, Knierim F, Rojas A, Cofre H. Survey on undiagnosed hydatidosis and cysticercosis by means of immunobiological reactions. Bol Chil Parasitol. 1971;26:121-123.
17. Rydzewski AK, Chisholm ES, Kagan IG. Comparison of serologic tests for human cysticercosis by indirect hemagglu- tination, indirect immunofluorescent antibody, and agar gel precipitin tests. J Parasitol. 1975;61:154-155.
18. Flisser A, Perez-Montfort R, Larralde C. The immunology of human and animal cysticercosis: a review. Bull World Health Organ. 1979;57:839-856.
19. Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry. 1971;8:871-874.
20. Arambulo PV, 3rd, Walls KW, Bullock S, Kagan IG. Serodiagnosis of human cysticercosis by microplate enzyme- linked immunospecific assay (ELISA). Acta Trop. 1978;35:63-67.
21. Coker-Vann MR, Subianto DB, Brown P, Diwan AR, Desowitz R, Garruto RM, et al. ELISA antibodies to cysticerci of Taenia solium in human populations in New Guinea, Oceania, and Southeast Asia. Southeast Asian J Trop Med Public Health. 1981;12:499-505.
22. Diwan AR, Coker-Vann M, Brown P, Subianto DB, Yolken R, Desowitz R, et al. Enzyme-linked immunosorbent assay (ELISA) for the detection of antibody to cysticerci of Taenia solium. Am J Trop Med Hyg. 1982;31:364-369.
23. Costa JM, Ferreira AW, Makino MM, Camargo ME. Spinal fluid immunoenzymatic assay (ELISA) for neurocysticercosis. Rev Inst Med Trop Sao Paulo. 1982;24:337-341.
24. Mohammad IN, Heiner DC, Miller BL, Goldberg MA, Kagan IG. Enzyme-linked immunosorbent assay for the diagnosis of cerebral cysticercosis. J Clin Microbiol. 1984;20:775-779.
25. Costa JM. Immunoenzymatic test (ELISA) in the diagnosis of neurocysticercosis: study of various antigenic extracts in the detection of IgG antibodies in serum and cerebrospinal fluid samples. Arq Neuro-psiquiatr. 1986;44:15-31.
26. Schantz PM, Shanks D, Wilson M. Serologic cross-reactions with sera from patients with echinococcosis and cysticercosis. Am J Trop Med Hyg. 1980;29:609-612.
27. Coker-Vann M, Brown P, Gajdusek DC. Serodiagnosis of human cysticercosis using a chromatofocused antigenic pre- paration of Taenia solium cysticerci in an enzyme-linked immunosorbent assay (ELISA). Trans R Soc Trop Med Hyg. 1984;78:492-496.
28. Gottstein B, Tsang VC, Schantz PM. Demonstration of species-specific and cross-reactive components of Taenia solium metacestode antigens. Am J Trop Med Hyg. 1986;35:308-313.
29. Mendoza J, Molina JM, Rojas A, Leiva J, Sanchez JC, de la Rosa M. Evaluation of 2 serological techniques in the diagnosis of neurocysticercosis: complement fixation reaction and Western blot. Enferm Infecc Microbiol Clin. 1991;9:537-542.
30. Chavarria A, Fleury A, Garcia E, Marquez C, Fragoso G, Sciutto E. Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles. Clin Immunol. 2005;116:271-278.
31. Flisser A, Woodhouse E, Larralde C. Human cysticercosis: antigens, antibodies and non-responders. Clin Exp Immunol. 1980;39:27-37.
32. Plancarte A, Flisser A, Larralde C. Fibronectin-like properties in antigen B from the cysticercus of Taenia solium. Cytobios. 1983;36:83-93.
33. Laclette JP, Merchant MT, Willms K. Histological and ultrastructural localization of antigen B in the metacestode of Taenia solium. J Parasitol. 1987;73:121-129.
34. Laclette JP, Landa A, Arcos L, Willms K, Davis AE, Shoemaker CB. Paramyosin is the Schistosoma mansoni (Trematoda) homologue of antigen B from Taenia solium (Cestoda). Mol Biochem Parasitol. 1991;44:287-295.
35. Espinoza B, Ruiz-Palacios G, Tovar A, Sandoval MA, Plancarte A, Flisser A. Characterization by enzyme-linked immunosorbent assay of the humoral immune response in patients with neurocysticercosis and its application in immunodiagnosis. J Clin Microbiol. 1986;24:536-541.
36. Correa D, Sandoval MA, Harrison LJ, Parkhouse RM, Plancarte A, Meza-Lucas A, et al. Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid. Trans R Soc Trop Med Hyg. 1989;83:814-816.
37. Das S, Mahajan RC, Ganguly NK, Sawhney IM, Dhawan V, Malla N. Detection of antigen B of Cysticercus cellulosae in cerebrospinal fluid for the diagnosis of human neurocysticer- cosis. Trop Med Int Health. 2002;7:53-58.
38. Grogl M, Estrada JJ, MacDonald G, Kuhn RE. Antigen- antibody analyses in neurocysticercosis. J Parasitol. 1985;71:433-442.
39. Tsang VC, Peralta JM, Simons AR. Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol. 1983;92:377-391.
40. Kim SI, Kang SY, Cho SY, Hwang ES, Cha CY. Purification of cystic fluid antigen of Taenia solium metacestodes by affinity chromatography using monoclonal antibody and its antigenic characterization. Kisaengch'unghak Chapchi. 1986;24:145-148.
41. Kumar D, Gaur SN. Serodiagnosis of porcine cysticercosis by enzyme-linked immunosorbent assay (ELISA) using fractionated antigens. Vet Parasitol. 1987;24:195-202.
42. Rossi CL. Evaluation of antigenic fractions of Cysticercus cellulosae for the immunodiagnosis of neurocysticercosis using antibody-lectin conjugates. Arq Neuro-psiquiatr. 1989;47: 287-290.
43. da Silva AD, Quagliato EM, Rossi CL. A quantitative enzyme-linked immunosorbent assay (ELISA) for the immu- nodiagnosis of neurocysticercosis using a purified fraction from Taenia solium cysticerci. Diagn Microbiol Infect Dis. 2000;37:87-92.
44. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immu- noelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis. 1989;159:50-59.
45. Feldman M, Plancarte A, Sandoval M, Wilson M, Flisser A. Comparison of two assays (EIA and EITB) and two samples (saliva and serum) for the diagnosis of neurocysticercosis. Trans R Soc Trop Med Hyg. 1990;84:559-562.
46. Diaz JF, Verastegui M, Gilman RH, Tsang VC, Pilcher JB, Gallo C, et al. Immunodiagnosis of human cysticercosis (Taenia solium): a field comparison of an antibody-enzyme- linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. The Cysticercosis Working Group in Peru (CWG). Am J Trop Med Hyg. 1992;46:610-615.
47. Schantz PM, Sarti E, Plancarte A, Wilson M, Criales JL, Roberts J, et al. Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. Clin Infect Dis. 1994;18:879-885.
48. Proano-Narvaez JV, Meza-Lucas A, Mata-Ruiz O, Garcia-Jeronimo RC, Correa D. Laboratory diagnosis of human neurocysticercosis: double-blind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay. J Clin Microbiol. 2002;40:2115-2118.
49. Gonzalez AE, Cama V, Gilman RH, Tsang VC, Pilcher JB, Chavera A, et al. Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg. 1990;43:194-199.
50. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis. 1991;164:1007-1009.
51. Singh G, Kaushal V, Ram S, Kaushal RK, Dhanuka AK, Khurana S. Cysticercus immunoblot assay in patients with single, small enhancing lesions and multilesional neurocysti- cercosis. J Assoc Phys India. 1999;47:476-479.
52. Greene RM, Wilkins PP, Tsang VC. Diagnostic glycoproteins of Taenia solium cysts share homologous 14- and 18-kDa subunits. Mol Biochem Parasitol. 1999;99:257-261.
53. Hancock K, Pattabhi S, Greene RM, Yushak ML, Williams F, Khan A, et al. Characterization and cloning of GP50, a Taenia solium antigen diagnostic for cysticercosis. Mol Biochem Parasitol. 2004;133:115-124.
54. Hancock K, Pattabhi S, Whitfield FW, Yushak ML, Lane WS, Garcia HH, et al. Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis. Mol Biochem Parasitol. 2006;147:109-117.
55. Kojic EM, White AC Jr. A positive enzyme-linked immunoe-lectrotransfer blot assay result for a patient without evidence of cysticercosis. Clin Infect Dis. 2003;36:e7-e9.
56. Furrows SJ, McCroddan J, Bligh WJ, Chiodini P. Lack of specificity of a single positive 50-kDa band in the electro- immunotransfer blot (EITB) assay for cysticercosis. Clin Microbiol Infect. 2006;12:459-462.
57. Tsang VC, Pilcher JA, Zhou W, Boyer AE, Kamango-Sollo EI, Rhoads ML, et al. Efficacy of the immunoblot assay for cysticercosis in pigs and modulated expression of distinct IgM/ IgG activities to Taenia solium antigens in experimental infections. Vet Immunol Immunopathol. 1991;29:69-78.
58. Plancarte A, Hirota C, Martinez-Ocana J, Mendoza- Hernandez G, Zenteno E, Flisser A. Characterization of GP39-42 and GP24 antigens from Taenia solium cysticerci and of their antigenic GP10 subunit. Parasitol Res. 1999;85:680-684.
59. Bueno EC, Scheel CM, Vaz AJ, Machado LR, Livramento JA, Takayanagui OM, et al. Application of synthetic 8-kD and recombinant GP50 antigens in the diagnosis of neurocys- ticercosis by enzyme-linked immunosorbent assay. Am J Trop Med Hyg. 2005;72:278-283.
60. Lee YM, Handali S, Hancock K, Pattabhi S, Kovalenko VA, Levin A, et al. Serologic diagnosis of human Taenia solium cysticercosis by using recombinant and synthetic antigens in QuickELISA. Am J Trop Med Hyg. 2011;84:587-593.
61. Hancock K, Khan A, Williams FB, Yushak ML, Pattabhi S, Noh J, et al. Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis. J Clin Microbiol. 2003;41:2577-2586.
62. Maddison SE, Slemenda SB, Schantz PM, Fried JA, Wilson M, Tsang VC. A specific diagnostic antigen of Echinococcus granulosus with an apparent molecular weight of 8 kDA. Am J Trop Med Hyg. 1989;40:377-383.
63. Poretti D, Felleisen E, Grimm F, Pfister M, Teuscher F, Zuercher C, et al. Differential immunodiagnosis between cystic hydatid disease and other cross-reactive pathologies. Am J Trop Med Hyg. 1999;60:193-198.
64. Monteiro KM, Scapin SM, Navarro MV, Zanchin NI, Cardoso MB, da Silveira NP, et al. Self-assembly and structural characterization of Echinococcus granulosus antigen B recombinant subunit oligomers. Biochim Biophys Acta. 2007;1774:278-285.
65. Jia WZ, Yan HB, Lou ZZ, Ni XW, Liu HX, Li HM, et al. Genetic variation of the 8-kDa glycoprotein family from Echinococcus granulosus, Taenia multiceps and Taenia hydati- gena. Chin Med J. 2011;124:2849-2856.
66. Rigano R, Profumo E, Bruschi F, Carulli G, Azzara A, Ioppolo S, et al. Modulation of human immune response by Echinococcus granulosus antigen B and its possible role in evading host defenses. Infect Immun. 2001;69:288-296.
67. Greene RM, Hancock K, Wilkins PP, Tsang VC. Taenia solium: molecular cloning and serologic evaluation of 14- and 18-kDa related, diagnostic antigens. J Parasitol. 2000;86:1001-1007.
68. Scheel CM, Khan A, Hancock K, Garcia HH, Gonzalez AE, Gilman RH, et al. Serodiagnosis of neurocysticercosis using synthetic 8-kD proteins: comparison of assay formats. Am J Trop Med Hyg. 2005;73:771-776.
69. Ferrer E, Sanchez J, Milano A, Alvarez S, La Rosa R, Lares M, et al. Diagnostic epitope variability within Taenia solium 8kDa antigen family: implications for cysticercosis immuno- detection. Exp Parasitol. 2012;130:78-85.
70. Simac C, Michel P, Andriantsimahavandy A, Esterre P, Michault A. Value of immunodiagnosis by ELISA and Western blotting for the diagnostic and therapeutic management of neurocysticercosis. Arch Inst Pasteur Madagascar. 1994;61:21-27.
71. Chung JY, Bahk YY, Huh S, Kang SY, Kong Y, Cho SY. A recombinant 10-kDa protein of Taenia solium metacestodes specific to active neurocysticercosis. J Infect Dise. 1999;180:1307-1315.
72. Ferrer E, Bonay P, Foster-Cuevas M, Gonzalez LM, Davila I, Cortez MM, et al. Molecular cloning and characterisation of Ts8B1, Ts8B2 and Ts8B3, three new members of the Taenia solium metacestode 8 kDa diagnostic antigen family. Mol Biochem Parasitol. 2007;152:90-100.
73. Ferrer E, Martinez-Escribano JA, Barderas ME, Gonzalez LM, Cortez MM, Davila I, et al. Peptide epitopes of the Taenia solium antigen Ts8B2 are immunodominant in human and porcine cysticercosis. Mol Biochem Parasitol. 2009;168:168-171.
74. Yang HJ, Chung JY, Yun D, Kong Y, Ito A, Ma L, et al. Immunoblot analysis of a 10 kDa antigen in cyst fluid of Taenia solium metacestodes. Parasite Immunol. 1998;20:483-488.
75. Baig S, Damian RT, Molinari JL, Tato P, Morales-Montor J, Welch M, et al. Purification and characterization of a metacestode cysteine proteinase from Taenia solium involved in the breakdown of human IgG. Parasitology. 2005;131(Pt 3):411-6.
76. Li AH, Moon SU, Park YK, Na BK, Hwang MG, Oh CM, et al. Identification and characterization of a cathepsin L-like cysteine protease from Taenia solium metacestode. Vet Parasitol. 2006;141:251-259.
77. Zimic M, Pajuelo M, Rueda D, Lopez C, Arana Y, Castillo Y, et al. Utility of a protein fraction with cathepsin L-like activity purified from cysticercus fluid of Taenia solium in the diagnosis of human cysticercosis. Am J Trop Med Hyg. 2009;80:964-970.
78. Pina R, Gutierrez AH, Gilman RH, Rueda D, Sifuentes C, Flores M, et al. A dot-ELISA using a partially purified cathepsin-L-like protein fraction from Taenia solium cysticerci, for the diagnosis of human neurocysticercosis. Ann Trop Med Parasitol. 2011;105:311-318.
79. Hernandez M, Beltran C, Garcia E, Fragoso G, Gevorkian G, Fleury A, et al. Cysticercosis: towards the design of a diagnostic kit based on synthetic peptides. Immunol Lett. 2000;71:13-17.
80. Fleury A, Beltran C, Ferrer E, Garate T, Harrison LJ, Parkhouse RM, et al. Application of synthetic peptides to the diagnosis of neurocysticercosis. Trop Med Int Health. 2003;8:1124-1130.
81. Ferrer E, Cortez MM, Cabrera Z, Rojas G, Davila I, Alarcon de Noya B, et al. Oncospheral peptide-based ELISAs as po- tential seroepidemiological tools for Taenia solium cysticercosis/neurocysticercosis in Venezuela. Trans R Soc Trop Med Hyg. 2005;99:568-576.
82. Noya O, Patarroyo ME, Guzman F, Alarcon de Noya B. Immunodiagnosis of parasitic diseases with synthetic peptides. Curr Protein Peptide Sci. 2003;4:299-308.
83. Handali S, Klarman M, Gaspard AN, Noh J, Lee YM, Rodriguez S, et al. Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticer- cosis and taeniasis. Clin Vaccine Immunol. 2010;17:68-72.
84. Handali S, Pattabhi S, Lee YM, Silva-Ibanez M, Kovalenko VA, Levin AE, et al. Development and evaluation of porcine cysticercosis QuickELISA in Triturus EIA analyzer. J Immunoassay Immunochem. 2010;31:60-70.
85. Salazar-Anton F, Lindh J. Taenia solium: a two-dimensional Western blotting method combined with the use of an EST-library for the identification of immunogenic proteins recognized by sera from neurocysticercosis patients. Exp Parasitol. 2011;128:371-376.
86. Prasad A, Prasad KN, Yadav A, Gupta RK, Pradhan S, Jha S, et al. Lymphocyte transformation test: a new method for diagnosis of neurocysticercosis. Diagn Microbiol Infect Dis. 2008;61:198-202.
87. Amit P, Prasad KN, Kumar GR, Shweta T, Sanjeev J, Kumar PV, et al. Immune response to different fractions of Taenia solium cyst fluid antigens in patients with neurocysticercosis. Exp Parasitol. 2011;127:687-692.
88. Manoutcharian K, Sotelo J, Garcia E, Cano A, Gevorkian G. Characterization of cerebrospinal fluid antibody specificities in neurocysticercosis using phage display peptide library. Clin Immunol. 1999;91:117-121.
89. Hell RC, Amim P, de Andrade HM, de Avila RA, Felicori L, Oliveira AG, et al. Immunodiagnosis of human neurocysticercosis using a synthetic peptide selected by phage-display. Clin Immunol. 2009;131:129-138.
90. da Silva Ribeiro V, Manhani MN, Cardoso R, Vieira CU, Goulart LR, Costa-Cruz JM. Selection of high affinity peptide ligands for detection of circulating antibodies in neurocysticercosis. Immunol Lett. 2010;129:94-99.
91. Manhani MN, Ribeiro VS, Cardoso R, Ueira-Vieira C, Goulart LR, Costa-Cruz JM. Specific phage-displayed pep tides discriminate different forms of neurocysticercosis by antibody detection in the serum samples. Parasite Immunol. 2011;33:322-329.
92. Esquivel-Velazquez M, Ostoa-Saloma P, Morales-Montor J, Hernandez-Bello R, Larralde C. Immunodiagnosis of neuro-cysticercosis: ways to focus on the challenge. J Biomed Biotechnol. 2011;2011:516042.
93. Handali S, Gonzalez AE, Hancock K, Garcia HH, Roberts JM, Gilman RH, et al. Porcine antibody responses to Taenia solium antigens rGp50 and sTs18var1. Am J Trop Med Hyg. 2004;71:322-326.
94. Corona T, Pascoe D, Gonzalez-Barranco D, Abad P, Landa L, Estanol B. Anticysticercous antibodies in serum and cerebrospinal fluid in patients with cerebral cysticercosis. J Neurol Neurosurg Psychiatry. 1986;49:1044-1049.
95. Michault A, Leroy D, Coubes P, Laporte JP, Bertil G, Mignard C. Immunologic diagnosis of the cerebrospinal fluid and serum in developing brain cysticercosis. Pathol Biol (Paris). 1989;37:249-253.
96. Zini D, Farrell VJ, Wadee AA. The relationship of antibody levels to the clinical spectrum of human neurocysticercosis. J Neurol Neurosurg Psychiatry. 1990;53:656-661.
97. Short JA, Heiner DC, Hsiao RL, Andersen FL. Immunoglobulin E and G4 antibodies in cysticercosis. J Clin Microbiol. 1990;28:1635-1639.
98. Intapan PM, Khotsri P, Kanpittaya J, Chotmongkol V, Maleewong W, Morakote N. Evaluation of IgG4 and total IgG antibodies against cysticerci and peptide antigens for the diagnosis of human neurocysticercosis by ELISA. Asian Pac J Allergy Immunol. 2008;26:237-244.
99. Huang B, Li G, Jia F, Liu F, Ge L, Li W, et al. Determination of specific IgG4 for diagnosis and therapeutic evaluation of cerebral cysticercosis. Chin Med J. 2002;115:580-583.
100. Malla N, Kaur R, Ganguly NK, Sawhney IM, Mahajan RC. Utility of specific IgG4 response in saliva and serum samples for the diagnosis and follow up of human neurocysticercosis. Nepal Med Coll J. 2005;7:1-9.
101. Garcia HH, Gonzalez AE, Gilman RH, Palacios LG, Jimenez I, Rodriguez S, et al. Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence. Am J Trop Med Hyg. 2001;65:31-32.
102. Sarti-Gutierrez EJ, Schantz PM, Lara-Aguilera R, Gomez Dandoy H, Flisser A. Taenia solium taeniasis and cysticercosis in a Mexican village. Trop Med Parasitol. 1988;39:194-198.
103. Schantz PM, Sarti-Gutierrez E. Diagnostic methods and epidemiologic surveillance of Taenia solium infection. Acta Leiden. 1989;57:153-163.
104. Diaz Camacho SP, Candil Ruiz A, Suate Peraza V, Zazueta Ramos ML, Felix Medina M, Lozano R, et al. Epidemiologic study and control of Taenia solium infections with praziquantel in a rural village of Mexico. Am J Trop Med Hyg. 1991;45: 522-531.
105. Gonzalez AE, Gilman R, Garcia HH, McDonald J, Kacena K, Tsang VC, et al. Use of sentinel pigs to monitor environmental Taenia solium contamination. The Cysticercosis Working Group in Peru (CWG). Am J Trop Med Hyg. 1994;51: 847-850.
106. McManus DP. Improved diagnosis as an aid to better surveillance of Taenia solium cysticercosis, a potential public health threat to Papua New Guinea. Papua New Guinea Med J. 1995;38:287-294.
107. Rodriguez-Canul R, Allan JC, Dominguez JL, Villegas S, Cob L, Rodriguez RI, et al. Application of an immunoassay to determine risk factors associated with porcine cysticercosis in rural areas of Yucatan, Mexico. Vet Parasitol. 1998;79:165-180.
108. Sahu PS, Parija SC, Narayan SK, Kumar D. Evaluation of an IgG-ELISA strategy using Taenia solium metacestode somatic and excretory-secretory antigens for diagnosis of neurocysti- cercosis revealing biological stage of the larvae. Acta Trop. 2009;110:38-45.
109. Aguilar-Rebolledo F, Meza-Lucas A, Torres J, Cedillo-Rivera R, Enciso A, Garcia RC, et al. Evaluation of the enzyme- linked immunoelectrotransfer blot assay for diagnosis of neurocysticercosis in children. J Child Neurol. 2002;17:416-420.
110. Barcelos IS, Ferreira MS, Moura LP, Biondi GF, Costa-Cruz JM. Use of the paired samples (cerebrospinal fluid and serum) in immunodiagnostic of active and inactive human neurocysticercosis. Mem Inst Oswaldo Cruz. 2005;100:427-429.
111. Cho SY, Kim SI, Kang SY, Choi DY, Suk JS, Choi KS, et al. Evaluation of enzyme-linked immunosorbent assay in serological diagnosis of human neurocysticercosis using paired samples of serum and cerebrospinal fluid. Kisaengch'unghak Chapchi. 1986;24:25-41.
112. Braga FM, dos Reis-Filho JB, de Camargo-Lima JG. Ventriculo-lumbar gradient of concentration of total cerebrospinal fluid proteins: 1- mechanisms of origin. Arq Neuro-psiquiatr. 1983;41:254-265.
113. Torres-Corzo JG, Tapia-Perez JH, Sanchez-Aguilar M, Della Vecchia RR, Chalita Williams JC, Cerda-Gutierrez R. Comparison of cerebrospinal fluid obtained by ventricular endoscopy and by lumbar puncture in patients with hydro- cephalus secondary to neurocysticercosis. Surg Neurol. 2009;71:376-379.
114. Miller B, Goldberg MA, Heiner D, Myers A, Goldberg A. A new immunologic test for CNS cysticercosis. Neurology. 1984;34:695-697.
115. Miller BL, Staugaitis SM, Tourtellotte WW, Shapshak P, Goldberg M, Heiner D, et al. Intra-blood-brain barrier IgG synthesis in cerebral cysticercosis. Arch Neurol. 1985;42:782-784.
116. Livramento JA. [A cerebrospinal fluid syndrome in neurocys- ticercosis]. Arq Neuro-psiquiatr. 1987;45:261-275.
117. Estanol B, Juarez H, Irigoyen Mdel C, Gonzalez-Barranco D, Corona T. Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel. J Neurol Neurosurg Psychiatry. 1989;52:254-257.
118. Estanol Vidal B, Diaz Granados J, Corona Vazquez T. Integrity of the blood-brain barrier and intrathecal synthesis of IgG in parenchymatous and subarachnoid cerebral cysticercosis. Rev Invest Clin. 1989;41:327-330.
119. Machado LR, Livramento JA, Vaz AJ, Bueno EC, Mielli SR, Bastouly V, et al. IgG intrathecal synthesis and specific antibody index in patients with neurocysticercosis. Arq Neuro-psiquiatr. 2002;60:395-399.
120. Jafri HS, Torrico F, Noh JC, Bryan RT, Balderrama F, Pilcher JB, et al. Application of the enzyme-linked immunoe-lectrotransfer blot to filter paper blood spots to estimate seroprevalence of cysticercosis in Bolivia. Am J Trop Med Hyg. 1998;58:313-315.
121. Fleury A, Bouteille B, Garcia E, Marquez C, Preux PM, Escobedo F, et al. Neurocysticercosis: validity of ELISA after storage of whole blood and cerebrospinal fluid on paper. Trop Med Int Health. 2001;6:688-693.
122. Wang LN, Ge LY, Miao F, Yu ZH, Liu YB, Zhen TM, et al. [Application of EITB in immunodiagnosis of cysticercosis]. Chin J Parasitol Parasitic Dis. 2004;22:98-100.
123. Ishida MM, Almeida MS, Espindola NM, Iha A, Pereira DA, Souza JG, et al. Seroepidemiological study of human cysticercosis with blood samples collected on filter paper, in Lages, State of Santa Catarina, Brazil, 2004-2005. Rev Soc Brasil Med Trop. 2011;44:339-343.
124. Handali S, Rodriguez S, Noh J, Gonzalez AE, Garcia HH, Gilman RH, et al. A simple method for collecting measured whole blood with quantitative recovery of antibody activities for serological surveys. J Immunol Methods. 2007;320:164-171.
125. Atluri SR, Singhi P, Khandelwal N, Malla N. Neurocysticercosis immunodiagnosis using Taenia solium cysticerci crude soluble extract, excretory secretory and lower molecular mass antigens in serum and urine samples of Indian children. Acta Trop. 2009;110:22-27.
126. Atluri SR, Singhi P, Khandelwal N, Malla N. Evaluation of excretory secretory and 10-30 kDa antigens of Taenia solium Cysticerci by EITB assay for the diagnosis of neurocysticercosis. Parasite Immunol. 2009;31:151-155.
127. Acosta E. Antibodies to the metacestode of Taenia solium in the saliva from patients with neurocysticercosis. J Clin Lab Anal. 1990;4:90-94.
128. Sahu PS, Parija SC, Sahu PK. Tear IgA-ELISA: a novel and sensitive method for diagnosis of ophthalmic cysticercosis. Acta Trop. 2008;106:168-174.
129. Estrada JJ, Kuhn RE. Immunochemical detection of antigens of larval Taenia solium and anti-larval antibodies in the cerebrospinal fluid of patients with neurocysticercosis. J Neurol Sci. 1985;71:39-48.
130. Tellez-Giron E, Ramos MC, Dufour L, Alvarez P, Montante M. Detection of Cysticercus cellulosae antigens in cerebrospinal fluid by dot enzyme-linked immunosorbent assay (Dot- ELISA) and standard ELISA. Am J Trop Med Hyg. 1987;37:169-173.
131. Estrada JJ, Estrada JA, Kuhn RE. Identification of Taenia solium antigens in cerebrospinal fluid and larval antigens from patients with neurocysticercosis. Am J Trop Med Hyg. 1989;41:50-55.
132. Choromanski L, Estrada JJ, Kuhn RE. Detection of antigens of larval Taenia solium in the cerebrospinal fluid of patients with the use of HPLC and ELISA. J Parasitol. 1990;76:69-73.
133. Harrison LJ, Joshua GW, Wright SH, Parkhouse RM. Specific detection of circulating surface/secreted glycoproteins of viable cysticerci in Taenia saginata cysticercosis. Parasite Immunol. 1989;11:351-370.
134. Brandt JR, Geerts S, De Deken R, Kumar V, Ceulemans F, Brijs L, et al. A monoclonal antibody-based ELISA for the detection of circulating excretory-secretory antigens in Taenia saginata cysticercosis. Int J Parasitol. 1992;22:471-477.
135. Draelants E, Brandt JR, Kumar V, Geerts S. Characterization of epitopes on excretory-secretory antigens of Taenia saginata metacestodes recognized by monoclonal antibodies with immunodiagnostic potential. Parasite Immunol. 1995;17:119-126.
136. Van Kerckhoven I, Vansteenkiste W, Claes M, Geerts S, Brandt J. Improved detection of circulating antigen in cattle infected with Taenia saginata metacestodes. Vet Parasitol. 1998;76:269-274.
137. Chen JP, Zhang XY, Tan W, Liu MF, Liu GL, Hu YX. Determination of circulating antigen in cysticercosis patients using McAb-based ELISA. Chin J Parasitol Parasitic Dis. 1991;9:122-125.
138. Wang CY, Zhang HH, Ge LY. A MAb-based ELISA for detecting circulating antigen in CSF of patients with neuro- cysticercosis. Hybridoma. 1992;11:825-827.
139. Wang CY, Li QS, Zhang HH, Su JJ, Zhang JJ, Li H, et al. Detection of CAg in CSF of 231 cerebral cysticercosis patients. Chin J Parasitol Parasitic Dis. 1993;11:276-278.
140. Harmsen MM, De Haard HJ. Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol. 2007;77:13-22.
141. Deckers N, Saerens D, Kanobana K, Conrath K, Victor B, Wernery U, et al. Nanobodies, a promising tool for species- specific diagnosis of Taenia solium cysticercosis. Int J Parasitol. 2009;39:625-633.
142. Garcia HH, Parkhouse RM, Gilman RH, Montenegro T, Bernal T, Martinez SM, et al. Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans R Soc Trop Med Hyg. 2000;94:673-676.
143. Fleury A, Hernandez M, Fragoso G, Parkhouse RM, Harrison LJ, Sciutto E. Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis. Trans R Soc Trop Med Hyg. 2003;97:542-546.
144. Deckers N, Kanobana K, Silva M, Gonzalez AE, Garcia HH, Gilman RH, et al. Serological responses in porcine cysticercosis: a link with the parasitological outcome of infection. Int J Parasitol. 2008;38:1191-1198.
145. Bobes RJ, Hernandez M, Marquez C, Fragoso G, Garcia E, Parkhouse RM, et al. Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up. Trop Med Int Health. 2006;11:943-950.
146. Fleury A, Hernandez M, Avila M, Cardenas G, Bobes RJ, Huerta M, et al. Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis. J Neurol Neurosurg Psychiatry. 2007;78:970-974.
147. Garcia HH, Dorny P, Castillo Y, Pretell EJ, Rodriguez S, Mija L, et al. Circulating antigen levels follow post-treatment evolution of subarachnoid neurocysticercosis. J Neuroparasitol. 2010;1:1-3.
148. Garcia HH, Harrison LJ, Parkhouse RM, Montenegro T, Martinez SM, Tsang VC, et al. A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg. 1998;92:411-414.
149. Nguekam, Zoli AP, Ongolo-Zogo P, Dorny P, Brandt J, Geerts S. Follow-up of neurocysticercosis patients after treatment using an antigen detection ELISA. Parasite (Paris, France). 2003;10:65-68.
150. Alexander AM, Prabhakaran V, Rajshekhar V, Muliyil J, Dorny P. Long-term clinical evaluation of asymptomatic subjects positive for circulating Taenia solium antigens. Trans R Soc Trop Med Hyg. 2010;104:809-810.
151. Aranda-Alvarez JG, Tapia-Romero R, Alcantara-Anguiano I, Meza-Lucas A, Mata-Ruiz O, Celis-Quintal G, et al. Human cysticercosis: risk factors associated with circulating serum antigens in an open community of San Luis Potosi, Mexico. Ann Trop Med Parasitol. 1995;89:689-692.
152. Correa D, Sarti E, Tapia-Romero R, Rico R, Alcantara-Anguiano I, Salgado A, et al. Antigens and antibodies in sera from human cases of epilepsy or taeniasis from an area of Mexico where Taenia solium cysticercosis is endemic. Ann Trop Med Parasitol. 1999;93:69-74.
153. Rodriguez-Hidalgo R, Benitez-Ortiz W, Praet N, Saa LR, Vercruysse J, Brandt J, et al. Taeniasis-cysticercosis in Southern Ecuador: assessment of infection status using multi- ple laboratory diagnostic tools. Mem Inst Oswaldo Cruz. 2006;101:779-782.
154. Krecek RC, Michael LM, Schantz PM, Ntanjana L, Smith MF, Dorny P, et al. Prevalence of Taenia solium cysticercosis in swine from a community-based study in 21 villages of the Eastern Cape Province, South Africa. Vet Parasitol. 2008;154:38-47.
155. Newell E, Vyungimana F, Geerts S, Van Kerckhoven I, Tsang VC, Engels D. Prevalence of cysticercosis in epileptics and members of their families in Burundi. Trans R Soc Trop Med Hyg. 1997;91:389-391.
156. Lin X, Li G, Huo H, Xu F, Li Q, Zhao Z. Detection of circulating antigen in serum and cerebrospinal fluid for diagnosis of cerebral cysticercosis. Chin J Parasitol Parasitic Dis. 1999;17:146-148.
157. Flisser A, Plancarte A, Correa D, Rodriguez-Del-Rosal E, Feldman M, Sandoval M, et al. New approaches in the diagnosis of Taenia solium cysticercosis and taeniasis. Ann Parasitol Hum Comp. 1990;65(Suppl 1):95-98.
158. Freilij HL, Corral RS, Katzin AM, Grinstein S. Antigenuria in infants with acute and congenital Chagas' disease. J Clin Microbiol. 1987;25:133-137.
159. Zheng HJ, Tao ZH, Reddy MV, Harinath BC, Piessens WF. Parasite antigens in sera and urine of patients with bancroftian and brugian filariasis detected by sandwich ELISA with monoclonal antibodies. Am J Trop Med Hyg. 1987;36:554-560.
160. Kremsner PG, de Jonge N, Simarro PP, Muhlschlegel F, Mir M, Sima FO, et al. Quantitative determination of circulating anodic and cathodic antigens in serum and urine of individuals infected with Schistosoma intercalatum. Trans R Soc Trop Med Hyg. 1993;87:167-169.
161. Parija SC, Ravinder PT, Rao KS. Detection of hydatid antigen in urine by countercurrent immunoelectrophoresis. J Clin Microbiol. 1997;35:1571-1574.
162. Parija M, Biswas R, Harish BN, Parija SC. Detection of specific cysticercus antigen in the urine for diagnosis of neurocysticercosis. Acta Trop. 2004;92:253-260.
163. Castillo Y, Rodriguez S, Garcia HH, Brandt J, Van Hul A, Silva M, et al. Urine antigen detection for the diagnosis of human neurocysticercosis. Am J Trop Med Hyg. 2009;80:379-383.
164. Mwape KE, Praet N, Benitez-Ortiz W, Muma JB, Zulu G, Celi-Erazo M, et al. Field evaluation of urine antigen detection for diagnosis of Taenia solium cysticercosis. Trans R Soc Trop Med Hyg. 2011;105:574-578.
165. Rajshekhar V. Etiology and management of single small CT lesions in patients with seizures: understanding a controversy. Acta Neurol Scand. 1991;84:465-470.
166. Sethi PP, Wadia RS, Kiyawat DP, Ichaporia NR, Kothari SS, Sangle SA, et al. Ring or disc enhancing lesions in epilepsy in India. J Trop Med Hyg. 1994;97:347-353.
167. Kumar Garg R, Kumar Singh M, Misra S. Single-enhancing CT lesions in Indian patients with seizures: a review. Epil Res. 2000;38:91-104.
168. Del Brutto OH. Solitary cysticercus granuloma in Latin America. In: Rajshekhar V, Chandy MJ, editors. Solitary cysticercus granuloma: the disappearing lesion. Chennai: Orient Longman; 2000. p. 153-163.
169. Garg RK. Single enhancing computerized tomography- detected lesion in immunocompetent patients. Neurosurg Focus. 2002;12:e4.
170. Carod-Artal FJ. Tropical causes of epilepsy. Rev Neurol. 2009;49:475-482.
171. Rajshekhar V, Oommen A. Utility of the cysticercus immunoblot in a patient with an atypical solitary cerebral cysticercus granuloma. Neurol India. 2001;49:75-77.
172. Garcia HH, Gonzalez AE, Rodriguez S, Tsang VC, Pretell EJ, Gonzales I, et al. Neurocysticercosis: unraveling the nature of the single cysticercal granuloma. Neurology. 2010;75:654-658.
173. Prabhakaran V, Rajshekhar V, Murrell KD, Oommen A. Conformation-sensitive immunoassays improve the serodiagnosis of solitary cysticercus granuloma in Indian patients. Trans R Soc Trop Med Hyg. 2007;101:570-577.
174. McManus DP. Molecular discrimination of taeniid cestodes. Parasitol Int. 2006;55(Suppl):S31-S37.
175. Almeida CR, Ojopi EP, Nunes CM, Machado LR, Takayanagui OM, Livramento JA, et al. Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis. Eur Arch Psychiatry Clin Neurosci. 2006;256:307-310.
176. Hernandez M, Gonzalez LM, Fleury A, Saenz B, Parkhouse RM, Harrison LJ, et al. Neurocysticercosis: detection of Taenia solium DNA in human cerebrospinal fluid using a semi-nested PCR based on HDP2. Ann Trop Med Parasitol. 2008;102:317-323.
177. Michelet L, Fleury A, Sciutto E, Kendjo E, Fragoso G, Paris L, et al. Human neurocysticercosis: comparison of different diagnostic tests using cerebrospinal fluid. J Clin Microbiol. 2011;49:195-200.
178. Ramahefarisoa RM, Rakotondrazaka M, Jambou R, Carod JF. Comparison of ELISA and PCR assays for the diagnosis of porcine cysticercosis. Vet Parasitol. 2010;173:336-339.
179. Praet N, Rodriguez-Hidalgo R, Speybroeck N, Ahounou S, Benitez-Ortiz W, Berkvens D, et al. Infection with versus exposure to Taenia solium: what do serological test results tell us? Am J Trop Med Hyg. 2010;83:413-415.
180. Handali S, Klarman M, Gaspard AN, Dong XF, Laborde R, Noh J, et al. Development and evaluation of a magnetic immunochromatographic test to detect Taenia solium, which causes taeniasis and neurocysticercosis in humans. Clin Vaccine Immunol. 2010;17:631-637.
181. Sato MO, Yamasaki H, Sako Y, Nakao M, Nakaya K, Plancarte A, et al. Evaluation of tongue inspection and serology for diagnosis of Taenia solium cysticercosis in swine: usefulness of ELISA using purified glycoproteins and recombinant antigen. Vet Parasitol. 2003;111:309-322.